Cancer Research Heroes, Our Impact, Press Release | 02.06.19 The Parker Institute for Cancer Immunotherapy Expands its Network to Include More Rising Stars in Cancer Immunotherapy
Press Release | 11.15.18 PsiOxus Therapeutics to Collaborate with the Parker Institute for Cancer Immunotherapy on Virus-Based Gene Therapy to Treat Solid Tumors
Press Release | 10.18.18 The Parker Institute for Cancer Immunotherapy Partners with Xyphos Biosciences to Develop Universal Programmable CAR-T Cells for Cancer Treatment
Press Release | 04.05.18 Parker Institute for Cancer Immunotherapy Scientists to Present Immuno-oncology Research on Personalized Cancer Vaccines, New Checkpoint Inhibitor Combinations, the Microbiome and Cell Therapy at AACR 2018
Press Release | 03.08.18 Parker Institute for Cancer Immunotherapy Scientist Kole Roybal of UCSF Wins Inaugural Sartorius & Science Prize for Regenerative Medicine & Cell Therapy
Press Release | 11.14.17 Seres Therapeutics, MD Anderson Cancer Center, and the Parker Institute for Cancer Immunotherapy Announce a Collaboration to Support the Investigation of Microbiome Therapeutics for Immuno-Oncology
Press Release | 10.16.17 Dana-Farber Cancer Institute Joins the Parker Institute for Cancer Immunotherapy
Press Release | 09.20.17 The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy
Press Release | 06.22.17 The Parker Institute for Cancer Immunotherapy Trains the Next Generation of Scientific Leaders in Cancer Immunotherapy
Press Release | 06.19.17 Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Strategic Alliance Agreement
Press Release | 06.01.17 Parker Institute for Cancer Immunotherapy Scientists to Present Research at ASCO 2017 on IDO Pathway Inhibitors, Novel CAR-Ts and the Microbiome’s Potential in Immunotherapy